Jim Cramer shines a spotlight on Novo Nordisk A/S (NVO) as “Canada’s backdoor” in a recent Insider Monkey report, highlighting the pharma giant’s daring strategies and thrilling growth prospects throughout North America
As Rocket Lab USA continues to innovate in the space industry, investors are weighing the potential of its stock. With recent developments in satellite launches and ambitious plans for expansion, analysts are evaluating if now is the right time to buy.